NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel
Open accessThe DOI matches its Crossref record; 22 of the 23 references it cites were found in a registry or an index.
Abstract
Paclitaxel (PTX) is one of the most effective anticancer agents. In clinical practice, however, high incidences of adverse reactions of the drug, for example, neurotoxicity, myelosuppression, and allergic reactions, have been reported. NK105, a micellar nanoparticle formulation, was developed to overcome these problems and to enhance the antitumour activity of PTX. Via the self-association process, PTX was incorporated into the inner core of the micelle system by physical entrapment through hydrophobic interactions between the drug and the well-designed block copolymers for PTX. NK105 was compared with free PTX with respect to their in vitro cytotoxicity, in vivo antitumour activity, pharmacokinetics, pharmacodynamics, and neurotoxicity. Consequently, the plasma area under the curve (AUC) values were approximately 90-fold higher for NK105 than for free PTX because the leakage of PTX from normal blood vessels was minimal and its capture by the reticuloendothelial system minimised. Thus, the tumour AUC value was 25-fold higher for NK105 than for free PTX. NK105 showed significantly potent antitumour activity on a human colorectal cancer cell line HT-29 xenograft as compared with PTX (P<0.001) because the enhanced accumulation of the drug in the tumour has occurred, probably followed by its effective and sustained release from micellar nanoparticles. Neurotoxicity was significantly weaker with NK105 than with free PTX. The neurotoxicity of PTX was attenuated by NK105, which was demonstrated by both histopathological (P<0.001) and physiological (P<0.05) methods for the first time. The present study suggests that NK105 warrants a clinical trial for patients with metastatic solid tumours.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The size of polymeric micelles currently in clinical trials are less than 100 nm [6, 7].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [7]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“NK105 exhibited 23% of drug loading with a hydrodynamic size of approx. 90 nm [7].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [7]
The cited source says what the claim attributes to it.
In the citing paper
“NK105 is composed of paclitaxel and modified mPEG-b-P(Asp) block copolymer (mPEG = 12,000 g/mol and P(Asp) = 8,000 g/mol) where half of the carboxylic groups P(Asp) block is modified with hydrophobic 4-phenyl-1-butanol to increase its hydrophobicity and improve drug incorporation [7].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [7]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Self-citationTumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565 · cited 1×
“Passive targeting is based on the so-called enhanced permeability and retention (EPR) effect (Matsumura and Maeda, 1986; Maeda et al, 2000).”
BackgroundSelf-citationRowinsky, E. K., & Donehower, R. C. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504133321507 · Cited by 1,924
Hypersensitivity reactions from taxol.
Weiss, R. B., Donehower, R. C., Wiernik, P. H., Ohnuma, T., Gralla, R. J., Trump, D. L., Baker, J. R., Van Echo, D. A., Von Hoff, D. D., & Leyland-Jones, B. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.7.1263 · Cited by 1,174
Micellar Nanocontainers Distribute to Defined Cytoplasmic Organelles
Savić, R., Luo, L., Eisenberg, A., & Maysinger, D. (2003) · Science · doi:10.1126/science.1078192 · Cited by 1,113
Barriers to Drug Delivery in Solid Tumors
Jain, R. K. (1994) · Scientific American · doi:10.1038/scientificamerican0794-58 · Cited by 1,069
Block copolymer micelles as vehicles for drug delivery
Kazunori, K., Glenn S., K., Masayuki, Y., Teruo, O., & Yasuhisa, S. (1993) · Journal of Controlled Release · doi:10.1016/0168-3659(93)90172-2 · Cited by 877
Self-citationKim, T.-Y., Kim, D.-W., Chung, J.-Y., Shin, S. G., Kim, S.-C., Heo, D. S., Kim, N. K., & Bang, Y.-J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0655 · Cited by 821
Ibrahim, N. K., Desai, N. P., Legha, S. S., Soon‐Shiong, P., Theriault, R. L., Rivera, E., Esmaeli, B., Ring, S. E., Bedikian, A. Y., Hortobágyi, G. N., et al. (2002) · PubMed · Cited by 705
Development of the polymer micelle carrier system for doxorubicin
Nakanishi, T., Fukushima, S., Okamoto, K., Suzuki, M., Matsumura, Y., Yokoyama, M., Okano, T., Sakurai, Y., & Kataoka, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00341-8 · Cited by 570
Self-citation
Research works printed but not linked: 1
- 2. Hamaguchi T, Matsumura Y, Shirao Y, Shimada Y, Yamada Y, Muro Y, Okusaka T, Ueno H, Ikeda M, Watanabe N (2003) Phase I study of novel drug delivery system, NK911, a polymer micelle encapsulated doxor- ubicin. Proc Am Soc Clin Oncol 22: 571
Cited by
Items 301–400 of 565
The Implications and Future Perspectives of Nanomedicine for Cancer Stem Cell Targeted Therapies
Singh, V. K., Saini, A., & Chandra, R. (2017) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2017.00052 · Cited by 32
The spatiotemporal journey of nanomedicines in solid tumors on their therapeutic efficacy
Qin, M., Xia, H., Xu, W., Chen, B., & Wang, Y. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115137 · Cited by 33
Advances in Microfluidic‐Based Core@Shell Nanoparticles Fabrication for Cancer Applications
Almeida, D., Gil, J. F., Guillot, A. J., Li, J., Pinto, R. J. B., Santos, H. A., & Gonçalves, G. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202400946 · Cited by 32
Sakai‐Kato, K., Un, K., Nanjo, K., Nishiyama, N., Kusuhara, H., Kataoka, K., Kawanishi, T., Goda, Y., & Okuda, H. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.027 · Cited by 31
Self-citationPhenylboronic acid-incorporated elastin-like polypeptide nanoparticle drug delivery systems
Chen, W., Ji, S., Qian, X.-P., Zhang, Y., Li, C., Wu, W., Wang, F., & Jiang, X. (2017) · Polymer Chemistry · doi:10.1039/c7py00330g · Cited by 29
Wei, Y., Ma, L., Zhang, L., & Xu, X. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s144322 · Cited by 31
Hu, X., Li, J., Lin, W., Huang, Y., Jing, X., & Xie, Z. (2014) · RSC Advances · doi:10.1039/c4ra06270a · Cited by 28
Biodegradable Block Copolymers and Their Applications for Drug Delivery
Soni, V., Pandey, V., Asati, S., Gour, V., & Tekade, R. K. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817909-3.00011-x · Cited by 33
Advances in personalized treatment of metastatic spine disease
Ahangar, P., Aziz, M., Rosenzweig, D. H., & Weber, M. H. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.04.41 · Cited by 27
Carie, A., Rios‐Doria, J., Costich, T. L., Burke, B., Slama, R., Skaff, H., & Sill, K. (2011) · Journal of Drug Delivery · doi:10.1155/2011/869027 · Cited by 28
Lekha Nair, K., Jagadeeshan, S., Nair, S. A., & Kumar, G. S. V. (2011) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-9-42 · Cited by 28
Araki, T., Kono, Y., Ogawara, K., Watanabe, T., Ono, T., Kimura, T., & Higaki, K. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-0020 · Cited by 29
Chen, C., Lin, W., Hsia, Y., & Lo, L. (2016) · Macromolecular Bioscience · doi:10.1002/mabi.201600191 · Cited by 27
Rational design of block copolymer self-assemblies in photodynamic therapy
Demazeau, M., Gibot, L., Mingotaud, A., Vicendo, P., Roux, C., & Lonetti, B. (2020) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.11.15 · Cited by 28
Polymeric Micelles for Drug Delivery
Wu, W., & Jiang, X. (2016) · Wiley eBooks · doi:10.1002/9783527694396.ch3 · Cited by 28
Nakamura, I., Ichimura, E., Goda, R., Hayashi, H. D., Mashiba, H., Nagai, D., Yokoyama, H., Onda, T., & Masuda, A. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s114356 · Cited by 28
Self-citationHarada, Y., Yamamoto, T., Sakai, M., Saiki, T., Kawano, K., Maitani, Y., & Yokoyama, M. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.11.016 · Cited by 27
Self-citationTrickler, W. J., Nagvekar, A. A., & Dash, A. K. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9911-5 · Cited by 25
Synthesis of α-Amino Acid N-Carboxyanhydrides
Laconde, G., Amblard, M., & Martínez, J. (2021) · Organic Letters · doi:10.1021/acs.orglett.1c02224 · Cited by 24
Kosaka, Y., Saeki, T., Takano, T., Aruga, T., Yamashita, T., Masuda, N., Koibuchi, Y., Osaki, A., Watanabe, J., & Suzuki, R. (2022) · International Journal of Nanomedicine · doi:10.2147/ijn.s372477 · Cited by 24
Epirubicin-Complexed Polypeptide Micelle Effectively and Safely Treats Hepatocellular Carcinoma
Zhang, Q., Ding, J., Lv, C., Xu, W., Sun, X., & Meng, X. (2015) · Polymers · doi:10.3390/polym7111521 · Cited by 25
Pharmaceutical Micelles: Combining Longevity, Stability, and Stimuli Sensitivity
Carstens, M. G., Rijcken, C. J. F., van Nostrum, C. F., & Hennink, W. E. (2008) · Fundamental biomedical technologies · doi:10.1007/978-0-387-76554-9_9 · Cited by 31
Ma, Y., Jiang, X., & Zhuo, R. (2013) · Journal of Polymer Science Part A Polymer Chemistry · doi:10.1002/pola.26794 · Cited by 24
Innovative strategies for effective paclitaxel delivery: Recent developments and prospects
Wileński, S., Koper, A., Śledzińska, P., Bebyn, M. G., & Koper, K. (2024) · Journal of Oncology Pharmacy Practice · doi:10.1177/10781552231208978 · Cited by 28
Seah, G. L., Yu, J. H., Koo, B. I., Lee, D. J., & Nam, Y. S. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb02323a · Cited by 24
Bioinspired Polymeric-based Core-shell Smart Nano-systems
Harwansh, R. K., Deshmukh, R., Barkat, M. A., & Rahman, M. A. (2019) · Pharmaceutical Nanotechnology · doi:10.2174/2211738507666190429104550 · Cited by 26
Rajabi, M., & Feyzbakhsh, H. (2025) · RSC Advances · doi:10.1039/d5ra05399d · Cited by 36
Recent Nanocarrier Approaches for Targeted Drug Delivery in Cancer Therapy
Bhatia, R., Sharma, A., Narang, R. K., & Rawal, R. K. (2020) · Current Molecular Pharmacology · doi:10.2174/1874467213666200730114943 · Cited by 24
Using GPCRs as Molecular Beacons to Target Ovarian Cancer with Nanomedicines
Khetan, R., Dharmayanti, C., Gillam, T. A., Kübler, E., Klingler‐Hoffmann, M., Ricciardelli, C., Oehler, M. K., Blencowe, A., Garg, S., & Albrecht, H. (2022) · Cancers · doi:10.3390/cancers14102362 · Cited by 24
Yin, J., Li, Z., Yang, T., Wang, J., Zhang, X., & Zhang, Q. (2010) · Journal of drug targeting · doi:10.3109/10611861003663531 · Cited by 23
Phillips, M. C., & Mousa, S. A. (2022) · Nanomedicine · doi:10.2217/nnm-2021-0361 · Cited by 24
Hori, K., Nishihara, M., & Yokoyama, M. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21848 · Cited by 21
Self-citationPolymeric Micelles for Formulation of Anti-Cancer Drugs
Lee, H., Soo, P. L., Liu, J., Butler, M., & Allen, C. J. (2006) · CRC Press eBooks · doi:10.1201/9781420006636-17 · Cited by 35
In Vivo Evaluation of Dual-Targeted Nanoparticles Encapsulating Paclitaxel and Everolimus
Houdaihed, L., Evans, J. C., & Allen, C. J. (2019) · Cancers · doi:10.3390/cancers11060752 · Cited by 21
Algorithm for Designing Nanoscale Supramolecular Therapeutics with Increased Anticancer Efficacy
Kulkarni, A. A., Pandey, P. R., Rao, P., Mahmoud, A., Goldman, A. J., Sabbisetti, V. S., Parcha, S., Natarajan, S. K., Chandrasekar, V., Dinulescu, D. M., et al. (2016) · ACS Nano · doi:10.1021/acsnano.6b00241 · Cited by 21
Conventional Chemotherapeutic Drug Nanoparticles for Cancer Treatment
Serpe, L. (2003) · Wiley eBooks · doi:10.1002/9783527610419.ntls0060 · Cited by 23
Emoto, S., Sunami, E., Yamaguchi, H., Ishihara, S., Kitayama, J., & Watanabe, T. (2014) · Surgery Today · doi:10.1007/s00595-014-0848-x · Cited by 20
The Role of Payload Hydrophobicity in Nanotherapeutic Pharmacokinetics
Norvaišas, P., & Žiemys, A. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23996 · Cited by 21
Lin, L. Y., Karwa, A. S., Kostelc, J. G., Lee, N. S., Dorshow, R. B., & Wooley, K. L. (2012) · Molecular Pharmaceutics · doi:10.1021/mp3000887 · Cited by 20
Chang, T., Pallavi, G., Stenzel, M. H., & Lord, M. S. (2016) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2016.04.019 · Cited by 21
Seah, G. L., Yu, J. H., Yang, M. Y., Kim, W. J., Kim, J.-H., Park, K., Cho, J., Kim, J. S., & Nam, Y. S. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.07.046 · Cited by 21
Feng, S., Zhou, J., Li, Z., Appelman, H. D., Zhao, L., Zhu, J., & Wang, T. D. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.110498 · Cited by 21
Nanotechnology and Pediatric Cancer: Prevention, Diagnosis and Treatment.
Zare‐Zardini, H., Amiri, A., Shanbedi, M., Taheri‐Kafrani, A., Sadri, Z., Ghanizadeh, F., Neámatzadeh, H., Sheikhpour, R., Boroujeni, F. K., Dehshiri, R. M., et al. (2015) · PubMed Central · Cited by 27
Abbasi, S. Z., Yousefi, G., Firuzi, O., & Mohammadi‐Samani, S. (2015) · Journal of Applied Polymer Science · doi:10.1002/app.43233 · Cited by 20
Yang, Y., Bteich, J., & Li, S. (2016) · The AAPS Journal · doi:10.1208/s12248-016-0014-z · Cited by 20
Nature nominee quercetin's anti‐influenza combat strategy—Demonstrations and remonstrations
Enkhtaivan, G., Muthu, M., PAUL, D. Z., Ethiraj, G., Chun, S., & Gopal, J. (2017) · Reviews in Medical Virology · doi:10.1002/rmv.1930 · Cited by 20
Jiang, J., Jin, L., Zhao, Z., Gao, P., Li, M., Zheng, X., & Li, F. (2025) · Nanoscale · doi:10.1039/d5nr02990b · Cited by 23
Matsumoto, Y., Miyamoto, Y., Cabral, H., Matsumoto, Y., Nagasaka, K., Nakagawa, S., Yano, T., Maeda, D., Oda, K., Kawana, K., et al. (2016) · Cancer Science · doi:10.1111/cas.12926 · Cited by 18
Self-citationHydrogels bearing bioengineered mimetic embryonic microenvironments for tumor reversion
Zhao, Y., Yan, H., Qiao, S., Zhang, L., Wang, T., Meng, Q., Chen, D., Lin, F., Guo, K. X., Li, C., et al. (2016) · Journal of Materials Chemistry B · doi:10.1039/c6tb00927a · Cited by 17
Breast cancer nanomedicine market update and other industrial perspectives of nanomedicine
Aulić, S., Marson, D., Laurini, E., Fermeglia, M., & Pricl, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820016-2.00016-1 · Cited by 22
Sheybanifard, M., Beztsinna, N., Bagheri, M., Buhl, E. M., Bresseleers, J., Varela-Moreira, A., Shi, Y., van Nostrum, C. F., van der Pluijm, G., Storm, G., et al. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119409 · Cited by 21
Umezawa, M., Haruki, M., Yoshida, M., Kamimura, M., & Soga, K. (2020) · Analytical Sciences · doi:10.2116/analsci.20scp09 · Cited by 18
Sugahara, S.-I., Kajiki, M., Kuriyama, H., & Kobayashi, T. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.223 · Cited by 18
Qizilbash, F. F., Sartaj, A., Qamar, Z., Kumar, S., Imran, M., Mohammed, Y., Ali, J., Baboota, S., & Ali, A. (2023) · Journal of drug targeting · doi:10.1080/1061186x.2023.2243403 · Cited by 18
Fan, Y. L., Hou, H. W., Tay, H. M., Guo, W. M., Berggren, P., & Loo, S. C. J. (2017) · AAPS PharmSciTech · doi:10.1208/s12249-017-0745-x · Cited by 18
Anti-tumor Effect of All-Trans Retinoic Acid Loaded Polymeric Micelles in Solid Tumor Bearing Mice
Chansri, N., Kawakami, S., Yokoyama, M., Yamamoto, T., Charoensit, P., & Hashida, M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9398-x · Cited by 17
Self-citationSolubility enhancement and drug release mechanism of polymeric micelles
Kenguva, G., Rout, S. R., Fatima, M., Dubey, S. K., Alexander, A., Abourehab, M. A. S., Kesharwani, P., & Dandela, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89868-3.00006-9 · Cited by 18
Benedetto, G., Vestal, C. G., & Richardson, C. A. (2015) · Targeted Oncology · doi:10.1007/s11523-015-0371-z · Cited by 16
Soo, P. L., Dunne, M., Liu, J., & Allen, C. J. (2008) · Springer eBooks · doi:10.1007/978-0-387-77668-2_12 · Cited by 17
Block copolymer micelles as long-circulating drug vehicles
Patha, A. S., Patil, T., Pandey, P. K., Kuche, K., Ghadi, R., & Jain, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91248-8.00008-8 · Cited by 19
Rothenfluh, D. A., & Hubbell, J. A. (2009) · Integrative Biology · doi:10.1039/b907627c · Cited by 17
Ōnishi, Y., Eshita, Y., Ji, R., Onishi, M., Kobayashi, T., Mizuno, M., Yoshida, J., & Kubota, N. (2014) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.5.238 · Cited by 15
Stimuli responsive polymer-based strategies for polynucleotide delivery
Uz, M., Altınkaya, S. A., & Mallapragada, S. K. (2017) · Journal of materials research/Pratt's guide to venture capital sources · doi:10.1557/jmr.2017.116 · Cited by 17
Stimuli-Responsive Poly(aspartamide) Derivatives and Their Applications as Drug Carriers
Zhang, G., Yi, H., & Bao, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168817 · Cited by 17
Intranasal micellar curcumin for the treatment of chronic asthma
Chawla, R., Sahu, B., Mishra, M., Rani, V., & Singh, R. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102922 · Cited by 15
Sawdon, A. J., & Peng, C. (2015) · Molecules · doi:10.3390/molecules20022857 · Cited by 15
Wani, F. A., Behera, K., & Patel, R. (2022) · ChemistrySelect · doi:10.1002/slct.202201928 · Cited by 18
Wang, L., Cai, M., Liu, Y., Yang, T., Zeng, Y., Zhang, Y., Li, Q., Zhu, B., & Ma, G. (2015) · Powder Technology · doi:10.1016/j.powtec.2015.01.041 · Cited by 14
Kao, H.-W., Chan, C.-J., Chang, Y., Hsu, Y., Lu, M., Wang, J. S.-J., Lin, Y.-Y., Wang, S.-J., & Wang, H. (2013) · Applied Radiation and Isotopes · doi:10.1016/j.apradiso.2013.05.011 · Cited by 14
Factors Influencing the Delivery Efficiency of Cancer Nanomedicines
Ullah, R., Wazir, J., Khan, F. U., Diallo, M. T., Ihsan, A. U., Mikrani, R., Aquib, M., & Zhou, X. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-020-01691-3 · Cited by 16
Yoshii, N., Fujimoto, K., & Okazaki, S. (2015) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2015.12.062 · Cited by 15
Critical Analysis of Cancer Therapy using Nanomaterials
Juillerat‐Jeanneret, L. (2003) · Wiley eBooks · doi:10.1002/9783527610419.ntls0066 · Cited by 14
Li, S., Li, T., Wang, X., Rahmatulla, A., Zhao, Y., Zhang, X., Liu, Y., & Chen, Y. (2025) · Journal of drug targeting · doi:10.1080/1061186x.2025.2514564 · Cited by 15
Braatz, D., Peter, J. H., Dimde, M., Quaas, E., Ludwig, K., Achazi, K., Schirner, M., Ballauff, M., & Haag, R. (2023) · Journal of Materials Chemistry B · doi:10.1039/d3tb00055a · Cited by 14
pH-Sensitive Polymers with their Important Applications (A Review)
Madhu, C. R., & Patel, B. H. (2024) · Current Physical Chemistry · doi:10.2174/0118779468296209240427102827 · Cited by 14
Trickler, W. J., Munt, D. J., Jain, N., Joshi, S. S., & Dash, A. K. (2011) · Nanomedicine · doi:10.2217/nnm.10.135 · Cited by 13
Eribulin shows high concentration and long retention in xenograft tumor tissues
Sugawara, M., Condon, K., Liang, E., DesJardins, C., Schuck, E. L., Kusano, K., & Lai, W. G. (2017) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-017-3369-7 · Cited by 13
Drug Delivery Using Theranostics: An Overview of its Use, Advantages and Safety Assessment
Chiari‐Andréo, B. G., Abuçafy, M. P., Manaia, E. B., da Silva, B. L., Rissi, N. C., Oshiro, J. A., & Chiavacci, L. A. (2019) · Current Nanoscience · doi:10.2174/1573413715666190618162321 · Cited by 13
Voon, S. H., Kue, C. S., Imae, T., Saw, W. S., Lee, H. B., Kiew, L. V., Chung, L. Y., & Yusa, S. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.10.023 · Cited by 13
Liu, Y., Fens, M. H. A. M., Lou, B., van Kronenburg, N. C. H., Maas-Bakker, R. F., Kok, R. J., Oliveira, S., Hennink, W. E., & van Nostrum, C. F. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12040338 · Cited by 13
In Vitro and In Vivo Tumor Models for the Evaluation of Anticancer Nanoparticles
Abreu, T. R., Biscaia-Caleiras, M., Gonçalves, N., Fonseca, N. A., & Moreira, J. N. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-58174-9_12 · Cited by 18
Guo, Z., Liu, T., Gao, Q., Wang, C., Wang, Q., Du, R., Liu, Y., Li, H., Huang, Y., Liu, Y., et al. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c01263 · Cited by 14
Austria, E. S., Jr., & Akhavan, B. (2025) · Nanoscale · doi:10.1039/d5nr00436e · Cited by 14
Optimal drug delivery for intraperitoneal paclitaxel (PTX) in murine model
Kitayama, J., Ishigami, H., Yamaguchi, H., Yamada, J., Soma, D., Miyato, H., Kamei, T., Lefor, A. K., & Sata, N. (2017) · Pleura and Peritoneum · doi:10.1515/pp-2017-0002 · Cited by 12
Bastakoti, B. P., & Liu, Z. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46144-3.00010-6 · Cited by 12
Co-Encapsulation of Paclitaxel and JQ1 in Zein Nanoparticles as Potential Innovative Nanomedicine
Celano, M., Gagliardi, A., Maggisano, V., Ambrosio, N., Bulotta, S., Fresta, M., Russo, D., & Cosco, D. (2022) · Micromachines · doi:10.3390/mi13101580 · Cited by 12
Meena, P., & Kishore, N. (2021) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2021.116718 · Cited by 13
Hori, K., Nishihara, M., Shiraishi, K., & Yokoyama, M. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22038 · Cited by 12
Self-citationFeio, D. C. A., Oliveira, N., Pereira, E. L. R., Morikawa, A. T., Muniz, J. A. P. C., Montenegro, R. C., Alves, A. P. N. N., de Lima, P. D. L., Maranhão, R. C., & Burbano, R. M. R. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s129153 · Cited by 12
Clinical applications of nanostructured drug delivery systems
Mendes, M., Sousa, J., Pais, A. A. C. C., & Vitorino, C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-102198-9.00004-1 · Cited by 13
Choi, H. S., Liu, T., Qiao, H., Chacko, A., Hu, S., Chen, S., Zhou, R., & Chen, I. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.07.034 · Cited by 12
Lee, J., Choi, M., & Song, I. (2026) · Archives of Pharmacal Research · doi:10.1007/s12272-026-01609-w · Cited by 14
Joshi, D. C., Ashokan, A., & Jayakannan, M. (2022) · ACS Applied Bio Materials · doi:10.1021/acsabm.2c00775 · Cited by 11
Lebleu, C., Plet, L., Moussy, F., Gitton, G., Moreira, R. D., Guduff, L., Burlot, B., Godiveau, R., Merry, A., Lecommandoux, S., et al. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122501 · Cited by 11
Ultrasonic Drug Delivery Using Micelles and Liposomes
Martins, A. M., Ahmed, S. E., Vítor, R. F., & Husseini, G. A. (2015) · Springer eBooks · doi:10.1007/978-981-287-470-2_29-1 · Cited by 12
Piao, L., Li, Y., Zhang, H., & Jiang, J. (2019) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2019.1565612 · Cited by 11
Drug delivery applications of injectable biomaterials
Overstreet, D. J., von Recum, H. A., & Vernon, B. L. (2011) · Elsevier eBooks · doi:10.1533/9780857091376.2.95 · Cited by 12
Soleimani, A., Moustafa, M. M. A. R., Borecki, A., & Gillies, E. R. (2014) · Canadian Journal of Chemistry · doi:10.1139/cjc-2014-0349 · Cited by 15
Umezawa, M., Ueya, Y., Ichihashi, K., Dung, D. T. K., & Soga, K. (2023) · Biomedical Materials & Devices · doi:10.1007/s44174-023-00073-0 · Cited by 12
Encapsulation of paclitaxel into date palm lipid droplets for enhanced brain cancer therapy
Yousfan, A., Moursel, N., & Hanano, A. (2024) · Scientific Reports · doi:10.1038/s41598-024-83715-7 · Cited by 11
Metadata
- Authors
- Hamaguchi, T., Matsumura, Y., Suzuki, M., Shimizu, K., Goda, R., Nakamura, I., Nakatomi, I., Yokoyama, M., Kataoka, K., & Kakizoe, T.
- Affiliations
- National Cancer Centre Japan (JP)
- Nippon Kayaku (Japan) (JP)
- NanoCarrier (Japan) (JP)
- Kanagawa Academy of Science and Technology (JP)
- The University of Tokyo (JP)
- Corresponding author
- Matsumura, Y
- Venue
- British Journal of Cancer
- Published
- 2005-03-22
- Volume
- 92
- Issue
- 7
- Pages
- 1240-1246
- ISSN
- 0007-0920 (ISSN-L)
- 1532-1827
- PMC
- PMC2361981
- OpenAlex
- W2112927879
- Cited by
- 565
- References
- 23
- Citations by year
- 2026: 12 · 2025: 17 · 2024: 18 · 2023: 18 · 2022: 23 · 2021: 23 · 2020: 29 · 2019: 21 · 2018: 27 · 2017: 36 · 2016: 41 · 2015: 50 · 2014: 40 · 2013: 29 · 2012: 33
- FWCI
- 10.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- www.springer.com/tdm (unspecified)
- Locations
- British Journal of Cancer (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Oncology › Cancer Treatment and Pharmacology
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- paclitaxel, micellar nanoparticles, nanoparticle drug delivery, neurotoxicity, antitumour activity, pharmacokinetics, pharmacodynamics, block copolymer micelles, colorectal cancer, HT-29 xenograft, drug leakage, sustained drug release, metastatic solid tumors
- MeSH terms
- Animals, Antineoplastic Agents, Phytogenic, Chemistry, Pharmaceutical, Colonic Neoplasms, Humans, Nervous System, Transplantation, Heterologous, Paclitaxel, Area Under Curve, Nanostructures, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.